Cargando…
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities
BACKGROUND: Unprotected and fragile elderly people in nursing homes experienced the highest mortality rates during the initial coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVE: Our aim was to study the role of two oral anti-inflammatory drugs, colchicine and prednisone, in elderly patients wi...
Autores principales: | Hernández-Rodríguez, José, Durán-Sanclemente, Julio, Prieto-González, Sergio, Araújo, Olga, Hospital-Vidal, Teresa, Casanovas, Georgina, Sapena, Víctor, Blanco, José Luis, López-Soto, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521010/ https://www.ncbi.nlm.nih.gov/pubmed/36173596 http://dx.doi.org/10.1007/s40261-022-01201-2 |
Ejemplares similares
-
Sarcoidosis and chronic hepatitis C: treatment with prednisone and
colchicine
por: Pereira, Eduardo Guimarães, et al.
Publicado: (2016) -
COVID-19, colchicine and glycemia
por: Ilias, Ioannis, et al.
Publicado: (2021) -
Colchicine as a Potential Treatment Choice for COVID-19 Patients in Developing Countries: COVID-19 and Colchicine
por: Ghang, Byeongzu, et al.
Publicado: (2022) -
Prednisone: COVID-19 infection: case report
Publicado: (2020) -
Prednisone/rituximab: COVID-19: case report
Publicado: (2021)